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Lymphoproliferative and Gamma Interferon Responses to Stress-
Regulated Mycobacterium avium subsp. paratuberculosis Recombinant
Proteins
Ratna B. Gurung,a Douglas J. Begg,a Auriol C. Purdie,a Kumudika de Silva,a John P. Bannantine,b Richard J. Whittingtona
Faculty of Veterinary Science, University of Sydney, Camden, NSW, Australiaa; Bacterial Diseases of Livestock Research Unit, USDA ARS National Animal Disease Center,
Ames, Iowa, USAb
Johne’s disease in ruminants is a chronic infection of the intestines caused by Mycobacterium avium subsp. paratuberculosis. An
important strategy to control disease is early detection, and a potentially efficient method for early detection is measurement of
cell-mediated immune responses developed by the host in response to exposure or infection. One method is to measure lym-
phoproliferation and cytokine release from the host cells when exposed to the organism or parts of the organism. In this study,
10 recombinant M. avium subsp. paratuberculosis proteins known to be upregulated under in vitro stress conditions were evalu-
ated by examining their ability to evoke memory as a result of exposure by vaccination or oral challenge with live Mycobacterium
avium subsp. paratuberculosis. Out of 10 proteins, MAP2698c was found to induce higher cell-mediated immune responses in
vaccinated and challenged sheep in comparison to healthy controls. The findings suggest that not all stress-regulated proteins
have the diagnostic potential to detect cell-mediated immune responses in ovine paratuberculosis.
Johne’s disease (JD) in ruminants is a chronic infection of theintestines caused by Mycobacterium avium subsp. paratubercu-
losis. In sheep, economic losses arise due to reduced production of
wool and lambs, mortalities, and culling. The disease is character-
ized by a long incubation period, and subclinical infection creates
a potential source of infection for uninfected animals. Animals are
infected with M. avium subsp. paratuberculosis early in life by the
fecal-oral route from contaminated pasture, in utero infection,
suckling infected dams (1, 2, 38), and aerosols (3). An important
strategy required for the management and control of JD is early
detection and culling of infected animals from the population.
Subclinically infected animals may have intermittent patterns of
M. avium subsp. paratuberculosis shedding; therefore, a confirma-
tive test by fecal culture and PCR may be of low diagnostic value in
the early stage of infection.
Following the ingestion of M. avium subsp. paratuberculosis via
contaminated feed, mycobacteria invade the gut mucosa and are
phagocytosed by antigen-presenting cells (APCs)—macrophages
and dendritic cells. Infected cells migrate to regional lymphoid
tissues and interact with lymphocytes to initiate adaptive immune
responses. Following antigen presentation, the T cells are primed
and then proliferate and differentiate into effector cells, producing
important cytokines such as gamma interferon (IFN-) required
for mounting cell-mediated immune responses to prevent pro-
gression of the disease into the clinical stage (4, 5). On subsequent
exposure to the same antigen, primed immune cells are activated,
proliferate, and produce IFN- as an effector to clear infection in
a more vigorous manner than in the initial exposure.
A potentially efficient method for detection of early infection is
by measuring cell-mediated immune responses developed by the
host in response to exposure or infection. IFN- is a key cytokine
produced by both  and by  T cells that upregulate major
histocompatibility complex class II molecules (6) and has been
used as an indicator of infection (7). This cytokine, secreted by
activated and proliferating T cells postexposure, may be exploited
for early diagnosis of JD.
Commonly used antigens to stimulate lymphocytes in whole
blood to elicit M. avium subsp. paratuberculosis-specific cell-me-
diated immune responses have been M. avium subsp. paratuber-
culosis whole-cell lysates, purified protein derivatives (PPDs), or
French-pressed antigens (8). The specificity of these crude whole-
cell-derived antigens tends to be low (9–13). Therefore, investiga-
tion of M. avium subsp. paratuberculosis antigens with potential
immunogenicity for diagnostic efficiency is required.
Several M. avium subsp. paratuberculosis proteins are differen-
tially regulated in response to in vitro physiological stress condi-
tions, similar to stress conditions encountered during intracellu-
lar survival in the host macrophage (14–16). M. avium subsp.
paratuberculosis may express these stress proteins in vivo to evade
host defense mechanisms, and the host may mount an early
immune response to these antigens. Furthermore, proteins
MAP2768c and MAP3273c were reported to play important roles
in M. avium subsp. paratuberculosis latency and have the ability to
induce IFN- production in M. avium subsp. paratuberculosis-
infected cattle (17). Therefore, the cell-mediated immune re-
sponse mounted by the host against other M. avium subsp. para-
tuberculosis-specific stress-regulated proteins may be important to
explore for diagnostic potential.
The aim of this study was to evaluate the lymphocyte prolifer-
ation and IFN- induction ability of stress-regulated M. avium
subsp. paratuberculosis recombinant proteins in sheep that were
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exposed to M. avium subsp. paratuberculosis in comparison to
unexposed healthy controls.
MATERIALS AND METHODS
Antigens. Ten recombinant M. avium subsp. paratuberculosis antigens
were used to stimulate lymphoproliferation and IFN- production (Table
1). Antigens were selected based on their upregulated transcriptomic (18)
and proteomic (15, 16) responses to physiological stress conditions and in
silico epitope prediction analysis (19). Two M. avium subsp. paratubercu-
losis antigens were produced as His-tagged recombinant proteins at the
Faculty of Veterinary Science, University of Sydney, Sydney, Australia, as
previously described (20). Briefly, gene-specific primers were designed to
include an attB1 site and attB2 site at the 5= end of each sequence. The
complete open reading frames of each gene were amplified by PCR using
Gateway Technology (Invitrogen, Australia). Amplified and purified PCR
products were cloned into donor vector pDONR221 (Invitrogen, Austra-
lia) and transformed into One Shot TOP10 chemically competent Esche-
richia coli cells (Invitrogen, Australia) to produce the entry clone. Purified
entry clones were subcloned into destination vector pET160-DEST with
an N-terminal 6His and Lumio tag (Champion pET160 Gateway ex-
pression kit with Lumio technology) (Invitrogen, Australia) and trans-
formed into One Shot TOP10 chemically competent E. coli cells to pro-
duce an expression clone. One Shot BL21 Star(DE3) cells (Invitrogen,
Australia) were transformed with purified expression clone. The trans-
formed culture was induced with 1 mM isopropyl--D-thiogalactopyra-
noside to express recombinant proteins. Recombinant proteins were ex-
tracted and purified by affinity liquid chromatography (AKTA purifier
system; GE Healthcare). The purified recombinant protein yield was de-
termined by a NanoDrop spectrophotometer set at an absorbance of 280
nm (Thermo Scientific).
Eight proteins were produced as maltose binding protein (MBP)-re-
combinant fusion proteins at the USDA ARS National Animal Disease
Centre, Ames, IA, as previously described (21, 22) (Table 1). Briefly, the
full-length coding sequence of the M. avium subsp. paratuberculosis pro-
tein was amplified using gene-specific primers and cloned into the
pMAL-c2 translational fusion expression vector. The vector and amplified
products were digested with XbaI and HindIII, and the ligated products
were transformed into E. coli DH5 cells. The overexpressed proteins
were extracted and purified by affinity chromatography with amylose
resin (New England BioLabs) columns. The purified MBP-fusion protein
yield was determined by a NanoDrop spectrophotometer set at an absor-
bance of 280 nm.
MAP 316v, a French-pressed M. avium subsp. paratuberculosis antigen
produced from the laboratory-passaged isolate 316v (a generous gift from
the Elizabeth Macarthur Agricultural Institute, New South Wales, Austra-
lia), was used for M. avium subsp. paratuberculosis-specific lymphocyte
proliferation and whole-blood stimulation for IFN- induction. Other
mycobacterial antigens, comprising purified protein derivatives from My-
cobacterium avium (PPD-A) and Mycobacterium bovis (PPD-B) (Prionics)
and a nonspecific pokeweed mitogen (PWM) (Sigma) were used as posi-
tive controls to induce whole-blood IFN- induction.
Animals and blood sampling. Blood samples were collected from Me-
rino sheep from an ongoing experimental infection trial at the Faculty of
Veterinary Science, University of Sydney. The experimental infection trial
was approved by the University of Sydney Animal Ethics Committee.
A total of 33 animals broadly categorized as unexposed or exposed to
M. avium subsp. paratuberculosis were included in the study. The unex-
posed animals (n  5) were healthy controls. M. avium subsp. paratuber-
culosis-exposed animals were subcategorized as follows: (i) vaccinated
(n  7) with commercial Gudair vaccine (Pfizer Animal Health); (ii)
orally challenged (n  11) with three doses of 10 ml of inoculum as
previously described (23), with each animal receiving 2.1  109 viable M.
avium subsp. paratuberculosis cells (sheep strain Telford 9.2), and (iii)
vaccinated with Gudair vaccine (cattle strain 316v) followed by oral chal-
lenge (n  10) as described above. Animals were 4 months of age when
vaccinated and 5 months of age when orally challenged (Fig. 1). All unex-
posed and exposed animals were managed on separate paddocks under
conventional Australian sheep farming conditions by grazing in open
paddocks. Vaccinated animals were given 1 ml of the required vaccine
formulation by subcutaneous injection behind the ear on the upper neck
region.
Blood samples (20 ml) were collected by venipuncture into lithium-
heparin tubes at 8 months of age or 3 months post-oral challenge (Fig. 1)
and 4 months post-Gudair vaccination. One tube of blood each was used
for the IFN- and proliferation assays.
IFN- assay. (i) Whole-blood stimulation. Heparinized blood (500
l per well) was placed in a 48-well plate (Falcon) and stimulated with 500
l of antigen at a final concentration of 10 g/ml of MAP 316v, PPD-A, or
PPD-B, 5 g/ml of PWM, 10 g/ml of His-tagged recombinant antigen,
or 20 g/ml of MBP-fusion recombinant antigen. All antigens were di-
luted in culture medium (RPMI 1640, 10% [vol/vol] fetal calf serum,
penicillin, streptomycin, -mercaptoethanol, L-glutamine) (GIBCO, Life
Technologies). The negative control consisted of culture medium alone.
The plate was incubated at 37°C in air supplemented with 5% CO2 for 48
h, as described previously (24). The plasma supernatant was then har-
vested and stored at 	20°C.
(ii) IFN- ELISA. The IFN- enzyme-linked immunosorbent assay
(ELISA) was performed as previously described (25, 26). A 96-well
TABLE 1 Recombinant antigens used in whole-blood stimulation for IFN- production and lymphoproliferation in PBMCs
Recombinant tag Antigen Function
% homology in straina:
K-10b 104c ATCC 25291d
His tag MAP2698c Acyl-acyl carrier protein desaturase 100 99 99
MAP3567 Hypothetical protein or possible reductase 100 99 99
MBP fusion MAP0187c Superoxide dismutase 100 99 99
MAP2487c Carbonic anhydrase 100 99 99
MAP3393c IMP biosynthesis 100 99 99
MAP3268 Heat shock proteins 18_3 and 18_2 100 99 99
MAP1560 Catalytic activity with thioesterases 100 100 99
MAP1588c Alkyl hydroperoxide reductase D 100 99 100
MAP1589c Alkyl hydroperoxide reductase C 100 99 99
MAP1017c Fatty acid metabolism 100 99 99
a Sequence homology of all 10 proteins to Mycobacterium tuberculosis H37Rv was 
90%. Protein sequence homology was as previously reported (19).
b M. avium subsp. paratuberculosis K-10.
c M. avium subsp. hominissuis 104.
d M. avium subsp. avium ATCC 25291.
Gurung et al.
832 cvi.asm.org Clinical and Vaccine Immunology
  
MaxiSorp microplate (Nunc, Denmark) was coated with mouse mono-
clonal anti-bovine IFN- antibody (IFN 6.19) (50 l/well), generously
provided by Gregers Jungersen (National Veterinary Institute, Denmark),
at a final concentration of 1.5 g/ml in phosphate-buffered saline (PBS).
The plate was incubated overnight at 4°C and then washed five times with
reverse osmosis water containing 0.05% (vol/vol) Tween 20 (RO Tween
water), using a 96-well plate washer (Tecan Trading AG, Switzerland).
PBS (50 l) and undiluted thawed plasma supernatant (50 l) were added
per well, and the plate was incubated for 1 h at room temperature (RT).
The plate was washed as described above, and 50 l of secondary antibody
(biotin-conjugated mouse monoclonal anti-IFN- antibody clone
CC302) (ABD Serotec, Oxford, United Kingdom) was added at a 0.5-
g/ml concentration in PBS. The plate was incubated for 1 h at RT. The
plate was washed as described above, and 50 l/well of horseradish per-
oxidase-streptavidin was added at a 0.01-g/ml concentration in PBS.
The plate was incubated for 1 h at RT and washed as described above. A
100-l aliquot of substrate 3=,3=, 5,5=-tetramethylbenzidine (Thermo
Fisher Scientific, Rockford, IL) was added to all of the required wells, and
the mixture was incubated in the dark for 30 min. The enzymatic reaction
was stopped by adding 50 l of 2 M sulfuric acid, and absorbance was
measured at the 450-nm wavelength using a plate reader (Multiskan As-
cent, ThermoElectron, Waltham, MA). Serum supernatants obtained
from blood samples stimulated by MAP 316v antigens were used as
known IFN- positive and negative plate controls. The response in culture
medium was subtracted from the response to each recombinant antigen
to obtain the antigen-specific IFN- response. The IFN- response in
stimulated whole blood was presented as an sample-to-positive (SP) ratio
using the following calculation (where OD is optical density): SP ratio 
(mean sample OD – mean negative control OD)/(mean positive control
OD – mean negative control OD).
Proliferation assay. (i) Isolation of PBMCs. Heparinized blood was
used to isolate peripheral blood mononuclear cells (PBMCs) by density
gradient centrifugation as previously described (9). Briefly, blood was
centrifuged at 1,455  g for 20 min at RT, and the buffy coat was collected
with a sterile pipette, diluted 1:3 in PBS, layered over Ficoll-Paque Plus
(Pharmacia) (1:2), and centrifuged at 754  g for 30 min with no braking
at RT. The cloudy layer of interface containing PBMCs was aspirated with
a sterile pipette and washed in PBS (30 ml) to remove platelets by centrif-
ugation at 233  g for 10 min at RT. The supernatant was discarded, and
the pellet was resuspended in 30 ml PBS. Cell concentration was deter-
mined using a handheld automated cell counter (Sceptre, EMD; Milli-
pore, Billerica, MA).
(ii) Fluorescent labeling and cell culture. The PBMCs were labeled
with the fluorescent tracking dye carboxy fluorescein diacetate succinimi-
dyl ester (CFSE) (Fluka, St. Louis, MO) as previously described (27).
Briefly, wash buffer (5% fetal calf serum in PBS) was used to obtain a
concentration of 10  106 cells/ml. The cells were labeled by adding CFSE
to a final concentration of 5 M and incubating the mixture in the dark
for 5 min. The labeling was stopped by adding a 10 volume of ice-cold
wash buffer. The cells were pelleted by centrifugation at 233  g for 10 min
at RT, and the supernatant was discarded. The pellet was resuspended in
the residual volume, and 10 ml wash buffer was added. Cells were pelleted
by centrifugation at 233  g for 10 min, the supernatant was discarded, the
cells were resuspended in the residual volume, and prewarmed culture
medium was added to obtain a cell suspension of 5  106/ml. A total of
5  105 cells per well (100 l) were added to a 96-well microplate con-
taining 100 l of medium alone (negative control) or 100 l of antigen.
MAP 316v antigen (10 g/ml) was used as an M. avium subsp. paratuber-
culosis-specific positive control. The concentrations of recombinant anti-
gens used were 10 and 20 g/ml of His-tagged and MBP-fusion recombi-
nants, respectively. The plates were then incubated for 6 days at 37°C in a
5% CO2-supplemented incubator. All stimulations were performed in
duplicate. Incubated plates were centrifuged at 233  g for 3 min at RT.
Supernatants were discarded by flicking the plates and wiping on tissue
paper (Kim Wipe; Kimberley-Clark Professional, Irving, TX). The plate
lids were put back on, and the cells were resuspended by brief vortexing.
The fluorescent-labeled cells were fixed by adding 200 l/well of 1% para-
formaldehyde in PBS (Sigma-Aldrich, St. Louis, MO). The plate was pro-
tected from light and stored at 4°C, and data were acquired within 3 days.
(iii) Flow cytometry and data acquisition. The flow cytometric data
were acquired on a high-throughput system on a FACSCalibur flow cy-
tometer (BD Biosciences, San Jose, CA) and analyzed using CellQuest Pro
software version 4.0 (BD Biosciences, San Jose, CA). The cells were char-
acterized by a density plot based on forward scatter (FSC) and side scatter
(SSC). Since an anti-ovine anti-CD3 antibody is not commercially avail-
able, mononuclear cells were selected based on size and granularity. This
population of proliferating and nonproliferating cells was analyzed by a
histogram depicting counts versus CFSE fluorescence. Nonproliferating
cells are represented by a peak of high fluorescence indicating that those
cells had retained the dye. Conversely, proliferating cells are represented
by a peak of lower fluorescence as they lose fluorescence with every mitotic
division. Cell proliferation data are presented as antigen-specific prolifer-
ation: % of antigen-specific proliferation – % of proliferation in culture
medium.
Data analysis. Comparison of lymphoproliferative and IFN- re-
sponses between healthy controls and exposed groups was analyzed by
analysis of variance (ANOVA) with a Bonferroni correction for multiple
comparison (28). The correlation between the lymphoproliferation and
IFN- responses in animals that were exposed either to vaccine or to the
live M. avium subsp. paratuberculosis inoculum was analyzed. Statistical
analysis and illustration were performed using GraphPad Prism 4.0
(GraphPad Software, Inc., La Jolla, CA).
RESULTS
IFN- induction. Six recombinant antigens (MAP2698c, MAP3567,
MAP0187c, MAP1560, MAP1588c, and MAP1589c) were found to
induce detectable levels of IFN- secretion (Fig. 2A). The response
was negligible from the other four recombinant antigens
(MAP2487c, MAP3393c, MAP3268, and MAP1017c). The IFN-
response to the majority of the antigens was stronger in the vacci-
nated or vaccinated and challenged groups of animals in compar-
ison to animals that were challenged alone. The IFN- response
within the groups showed substantial variation in OD values, in-
dicating variation in response by individual animals. All of the
healthy control animals had negligible levels of IFN- response.
FIG 1 Experimental timeline. The timeline includes exposure (vaccination
with Gudair vaccine and oral challenge with cultured clonal inoculum of M.
avium subsp. paratuberculosis) and blood sampling. The light arrow, dark ar-
row, and arrowhead indicate the time points of vaccination, oral challenge,
and blood sampling, respectively.
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Whole-blood stimulation by antigens MAP1588c and MAP1589c
showed higher IFN- responses in animals that were both vacci-
nated and challenged in comparison to animals that were chal-
lenged or vaccinated alone. Among all recombinant antigens,
MAP2698c, MAP3567, and MAP1560 induced the greatest IFN-
response.
The French-pressed MAP 316v antigen induced a strong M.
avium subsp. paratuberculosis-specific immune memory IFN-
recall from all three groups exposed to M. avium subsp. paratu-
berculosis via either vaccination or oral challenge alone or vacci-
nation and challenge (Fig. 2B). All four groups of animals had a
strong nonspecific IFN- response when stimulated with PWM, a
nonspecific positive-control mitogen (Fig. 2B). The exposed
groups of animals showed significantly higher IFN- responses in
comparison to healthy controls when stimulated with either
PPD-A or MAP 316v antigens (Fig. 2B). The PPDs derived from
M. bovis (PPD-B) evoked weaker responses than PPD-A.
Cell proliferation. Figure 3 presents representative results of
flow cytometry from a vaccinated sheep in response to stimulation
with culture medium (Fig. 3A), test antigen (MAP2698c) (Fig.
3B), and positive-control antigen MAP 316v (Fig. 3C). After 6
days of culture, a high level of lymphoproliferation was observed
to antigens MAP2698c and MAP 316v compared to culture me-
dium alone. The proliferating cells in response to the MAP2698c
and MAP 316v antigens were detected as low-fluorescence-inten-
sity peaks of CFSE compared to a negligible amount of prolifera-
tion in culture medium (Fig. 3D).
Mean lymphoproliferation responses in each exposed group
were analyzed. Although statistically not significant, the mean
proliferative responses in exposed groups were empirically higher
than those of the healthy control group (Fig. 4A). Within the
exposed groups, three antigens (MAP2698c, MAP3567, and
MAP1589c) were able to induce higher levels of lymphoprolifera-
tion in the groups vaccinated alone or vaccinated and challenged
than in the group challenged alone. Antigens MAP0187c,
MAP2487c, and MAP1588c induced weaker proliferation re-
sponses in the vaccinated group compared to the infected-alone or
vaccinated and challenged groups. Among all antigens, four anti-
gens (MAP2698c, MAP3567, MAP0187c, and MAP1589c)
showed the highest lymphoproliferative responses.
Lymphoproliferative activity in all three exposed groups in re-
sponse to the MAP 316v antigen was higher than that in the
healthy control group. The response in the vaccinated group was
significantly higher than that in the control group (P 
 0.05)
(Fig. 4B).
Relationship between lymphoproliferation and IFN- re-
sponse. The relationship between lymphoproliferation and the
IFN- response was examined by calculating the coefficient of
correlation (r) in the exposed groups of animals. The responses
were significantly correlated for two antigens: MAP2698c (r 
0.53, P  0.003) and MAP3567 (r  0.61, P  0.001).
DISCUSSION
This study reports the evaluation of the ability of 10 recombinant
M. avium subsp. paratuberculosis antigens to evoke lymphoprolif-
erative and IFN- responses in M. avium subsp. paratuberculosis-
sensitized animals. Antigen-specific IFN- induction was mea-
sured by an IFN- ELISA, and lymphoproliferation was measured
by flow cytometry of CFSE-labeled PBMCs.
Among the 10 antigens evaluated, antigens prepared from
MAP2698c, MAP3567, MAP1589c, and MAP1560 were found to
induce lymphoproliferative and IFN- responses in animals that
FIG 2 IFN- response as recalled by recombinant proteins. Shown are the IFN- response to recombinant antigen-specific stimulation (A) and the IFN-
response to nonspecific antigen (PWM), mycobacterial species-specific antigens (PPD-A and PPD-B), and MAP 316v antigen (B). The results are presented as
sample-to-positive (SP) ratios. Significant differences in the mean between the healthy control and exposed (vaccinated or challenged alone and vaccinated and
challenged) groups are shown by asterisks (P 
 0.05). Error bars represent the standard errors of the SP ratio.
Gurung et al.
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were exposed to a vaccine containing M. avium subsp. paratuber-
culosis immunogen and/or challenged with M. avium subsp. para-
tuberculosis compared to controls. In silico epitope prediction of
MAP2698c and MAP3567 proteins found that they carry a higher
number of T-cell epitopes than the other antigens examined (19).
Transcriptomic studies have reported that genes encoding these
four proteins are upregulated when exposed to different in vitro
stress conditions (18, 29, 30). Furthermore, MAP2698c is an or-
tholog of Rv1094 of Mycobacterium tuberculosis, which plays an
important role in the intracellular survival and growth of myco-
bacteria and the pathogenicity of mycobacterial infection (31).
MAP3567 and MAP2698c were also reported to be recognized by
serum antibody of sheep infected with M. avium subsp. paratu-
berculosis (20).
Lymphocyte proliferation using the MAP 316v antigen in
sheep PBMCs has been reported as early as 4 months postchal-
lenge, with peak proliferation at 8 months postchallenge (9).
There were similar findings in this study using MAP 316v antigen
FIG 3 Flow cytometric data of antigen-specific cell proliferation. Shown are density scatter plots of proliferating gated R1 cells (lymphocytes and monocytes) in
response to stimulation by culture medium (A), recombinant MAP2698c (B), and MAP 316v antigen (C), as well as a histogram (D) of event counts against
fluorescence intensity for proliferation comparison in response to culture medium, recombinant MAP2698c, and MAP 316v antigens. The M1 marker encom-
passes proliferating cells with lower fluorescence intensity. SSCH, side scatter; FSCH, forward scatter.
FIG 4 Lymphoproliferative response to recombinant proteins. (A) Lymphoproliferative response to recombinant M. avium subsp. paratuberculosis antigens; (B)
lymphoproliferative response to MAP 316v antigen. The results are presented as percentages of antigen-specific proliferation. Significant differences in the mean
compared to the healthy control group are shown by asterisks (P 
 0.05). Error bars represent the standard errors of the percentage of proliferation.
Cell-Mediated Immune Response to Dormancy Proteins
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as a positive control. In comparison to the responses to MAP 316v
and mycobacterial PPDs, the single recombinant antigen showed
weaker responses of lymphoproliferation and IFN- secretion.
However, it should be noted that the proliferative response to
MAP 316v antigen is a cumulative response to the large number of
proteins that it contains. It is possible that the purified antigen
may not be taken up by antigen-presenting cells (APCs) in the
same way as complex antigens, such as PPD or whole mycobacte-
rial lysates, and that this may account for variation in the level of
response found. However, similar studies using the purified pro-
tein ESAT-6 in the diagnosis of bovine tuberculosis have yielded
robust responses (32). Another reason for the poor lymphoprolif-
eration response may be due to the possibility of purified antigen
containing endotoxins. Endotoxins may induce or be detrimental
to the proliferation of PBMCs. Although the antigens used in this
study were purified by affinity chromatography, and bound pro-
tein was washed with excessive amounts of buffer and then dia-
lyzed in phosphate buffered saline, they were not tested for the
presence of endotoxin.
It was disappointing to note that the lymphoproliferative and
IFN- responses to these recombinant antigens were not signifi-
cantly different from those of the control and far weaker than that
of MAP 316v antigen. The findings suggest that not all M. avium
subsp. paratuberculosis proteins known to be differentially regu-
lated under stress conditions are of potential diagnostic value, as
found by other studies (33, 34). There is a need to investigate other
M. avium subsp. paratuberculosis proteins for diagnostic value.
The weak response of lymphoproliferation and IFN- secre-
tion to recombinant antigens may also be attributed to the evalu-
ation performed at early time points, which in this study were 3
months postchallenge and 4 months postvaccination. The re-
sponses at later time points may be stronger but were out of the
scope of this study. Therefore, a longitudinal study combined with
larger sample size at later time points postvaccination and/or
postchallenge may provide further information on the immuno-
genic potential of these antigens. The level of IFN- produced also
depends on sites of infection and polarity of disease (5, 35). High
IFN- responses were reported in peripheral blood, gut, and pr-
escapular lymph nodes of vaccinated animals, spleen and postje-
junal lymph nodes of clinically affected animals, and only in pe-
ripheral blood of unvaccinated animals that were uninfected
following experimental challenge (36, 37). The IFN- response
measured in this study was only from peripheral blood samples.
Lymphoproliferation was found to be positively correlated to
IFN- production. However, the correlation was weak for the ma-
jority of the proteins, which may be due to the small sample size in
each group, with high variation in individual animal responses.
Lymphoproliferation and IFN- responses in this study were
found to be by and large a vaccine effect rather than a M. avium
subsp. paratuberculosis challenge effect because the response in
animals that received vaccine alone and vaccine followed by M.
avium subsp. paratuberculosis challenge was higher than that in
the group challenged alone. This effect supports the hypothesis
that live virulent M. avium subsp. paratuberculosis (oral inocu-
lum) leads to evasion of host defense mechanisms, causing the
host to fail or to delay mounting an immune response, compared
to heat-killed M. avium subsp. paratuberculosis (vaccine), which is
easily screened and to which the host mounts a strong immune
response. This effect also reflects the potential of Gudair vaccina-
tion to induce strong cell-mediated immune responses and anti-
body-mediated responses, as previously reported (13).
The four recombinant antigens (MAP2698c, MAP3567,
MAP1589c, and MAP1560) found to induce lymphoproliferative
and IFN- responses in this study may need further evaluation,
possibly in combination with other antigens.
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